Wells Fargo’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,464
Closed -$3.14K 7319
2023
Q3
$3.14K Sell
2,464
-73,443
-97% -$93.7K ﹤0.01% 5656
2023
Q2
$24.7K Sell
75,907
-70,826
-48% -$23.1K ﹤0.01% 5380
2023
Q1
$63.1K Buy
146,733
+88,629
+153% +$38.1K ﹤0.01% 4762
2022
Q4
$30.8K Sell
58,104
-30,714
-35% -$16.3K ﹤0.01% 4768
2022
Q3
$64K Buy
88,818
+212
+0.2% +$153 ﹤0.01% 4532
2022
Q2
$101K Buy
88,606
+29,172
+49% +$33.3K ﹤0.01% 4380
2022
Q1
$123K Buy
59,434
+23,936
+67% +$49.5K ﹤0.01% 4905
2021
Q4
$102K Sell
35,498
-336
-0.9% -$965 ﹤0.01% 5224
2021
Q3
$151K Buy
35,834
+506
+1% +$2.13K ﹤0.01% 4925
2021
Q2
$186K Buy
35,328
+6,400
+22% +$33.7K ﹤0.01% 4766
2021
Q1
$134K Buy
28,928
+26,458
+1,071% +$123K ﹤0.01% 5020
2020
Q4
$8K Buy
2,470
+831
+51% +$2.69K ﹤0.01% 5793
2020
Q3
$5K Sell
1,639
-2,792
-63% -$8.52K ﹤0.01% 5700
2020
Q2
$15K Sell
4,431
-17,893
-80% -$60.6K ﹤0.01% 5443
2020
Q1
$86K Sell
22,324
-2,051
-8% -$7.9K ﹤0.01% 4937
2019
Q4
$147K Buy
24,375
+8,058
+49% +$48.6K ﹤0.01% 4947
2019
Q3
$123K Buy
16,317
+12,112
+288% +$91.3K ﹤0.01% 5005
2019
Q2
$57K Buy
4,205
+2,204
+110% +$29.9K ﹤0.01% 5229
2019
Q1
$10K Sell
2,001
-838
-30% -$4.19K ﹤0.01% 5530
2018
Q4
$8K Sell
2,839
-5,467
-66% -$15.4K ﹤0.01% 5599
2018
Q3
$68K Sell
8,306
-49,515
-86% -$405K ﹤0.01% 5233
2018
Q2
$563K Buy
57,821
+16,407
+40% +$160K ﹤0.01% 4266
2018
Q1
$360K Buy
41,414
+6,782
+20% +$59K ﹤0.01% 4499
2017
Q4
$434K Buy
34,632
+553
+2% +$6.93K ﹤0.01% 4383
2017
Q3
$285K Buy
34,079
+33,196
+3,759% +$278K ﹤0.01% 4561
2017
Q2
$15K Buy
883
+200
+29% +$3.4K ﹤0.01% 5358
2017
Q1
$14K Sell
683
-204
-23% -$4.18K ﹤0.01% 5415
2016
Q4
$14K Buy
887
+387
+77% +$6.11K ﹤0.01% 5385
2016
Q3
$7K Buy
500
+400
+400% +$5.6K ﹤0.01% 5516
2016
Q2
$1K Sell
100
-254
-72% -$2.54K ﹤0.01% 5707
2016
Q1
$3K Buy
354
+247
+231% +$2.09K ﹤0.01% 5707
2015
Q4
$1K Sell
107
-7
-6% -$65 ﹤0.01% 5804
2015
Q3
$1K Buy
+114
New +$1K ﹤0.01% 5783